PPL67 Company Profile

Terran Orbital Corporation released Sales of $31.923 millions, in the most recent fiscal period

the Aerospace & Defense company revealed $31.923 millions, in Sales in the fourth quarter of 2022 earnings season.

Business outlays have been on the rise at the Tcr2 Therapeutics Inc in the fiscal fourth quarter of 2022

While the earnings cycle of fiscal October to December 31 2022 season continues, the most entities have declared their earnings. In the thick of it, have been various entities in the Biotechnology & Pharmaceuticals sector. As well as, today, TCRR disclosed operating shortfall of $-61.422 millions, for the financial fourth quarter of 2022.

An eye-catching slump in Sales at Meta Materials Inc amid the fourth quarter of 2022 earnings season

For the fiscal period closing December 31 2022 Meta Materials Inc decreased a loss per share of $-0.03 per share compare to $-0.22 a year prior and EPS improved from $-0.07 per share from the previous financial reporting period.

Sales faded by -49.855 % to $1.45 millions from $2.88 millions in the corresponding financial reporting period a year prior and sequentially Sales Tumbled by -41.135 % from $2.46 millions.

For the fiscal time-frame closing December 31 2022 Solid Biosciences Inc decreased a loss per share of $-0.13 per share compare to $-0.16 a year before and earnings per share improved from $-2.71 per share from the preceding quarter.

Sales remained unchanged to $0.00 millions from $3.15 millions in the similar quarter a year before and sequentially Sales Tumbled from $0.00 millions.

The Top-line took a nose-dive at the company in the fiscal fourth quarter of 2022

For the October to December 31 2022 interval company decreased a loss per share of $-0.32 per share compare to $-0.60 a year ago and EPS improved from $-0.42 per share from the prior quarter.

Sales crumbled by -29.802 % to $1.24 millions from $1.77 millions in the comparable quarter a year ago and sequentially Sales doubled by 334.737 % from $0.29 millions.